41.90
Schlusskurs vom Vortag:
$41.20
Offen:
$40.94
24-Stunden-Volumen:
2.26M
Relative Volume:
0.98
Marktkapitalisierung:
$6.02B
Einnahmen:
$3.24B
Nettoeinkommen (Verlust:
$304.90M
KGV:
20.14
EPS:
2.08
Netto-Cashflow:
$156.70M
1W Leistung:
+5.61%
1M Leistung:
+14.13%
6M Leistung:
-28.55%
1J Leistung:
-32.80%
Bruker Corp Stock (BRKR) Company Profile
Firmenname
Bruker Corp
Sektor
Branche
Telefon
978663-3660
Adresse
40 MANNING RD, BILLERICA, MA
Vergleichen Sie BRKR mit anderen Aktien
Aktien | Preis | Marktkapitalisierung | Umsatz | Nettogewinn | Free Cashflow | ENV |
---|---|---|---|---|---|---|
![]()
BRKR
Bruker Corp
|
41.90 | 6.02B | 3.24B | 304.90M | 156.70M | 2.08 |
![]()
ABT
Abbott Laboratories
|
136.25 | 233.36B | 42.34B | 13.50B | 6.66B | 7.71 |
![]()
BSX
Boston Scientific Corp
|
104.80 | 147.06B | 17.55B | 2.03B | 2.72B | 1.37 |
![]()
SYK
Stryker Corp
|
396.83 | 145.64B | 23.22B | 2.86B | 3.58B | 7.40 |
![]()
MDT
Medtronic Plc
|
88.74 | 112.76B | 33.54B | 4.66B | 5.19B | 3.62 |
![]()
EW
Edwards Lifesciences Corp
|
77.20 | 44.46B | 5.54B | 4.18B | 623.10M | 7.00 |
Bruker Corp Stock (BRKR) Upgrades & Downgrades
Datum | Aktion | Analytiker | Ratingänderung |
---|---|---|---|
2025-05-22 | Herabstufung | Citigroup | Buy → Neutral |
2024-12-19 | Eingeleitet | Guggenheim | Buy |
2024-12-10 | Eingeleitet | UBS | Neutral |
2024-12-05 | Hochstufung | Goldman | Sell → Neutral |
2024-10-15 | Eingeleitet | Barclays | Overweight |
2024-09-30 | Herabstufung | Wolfe Research | Outperform → Peer Perform |
2024-08-28 | Eingeleitet | Wells Fargo | Overweight |
2024-06-03 | Fortgesetzt | Jefferies | Buy |
2024-02-14 | Hochstufung | JP Morgan | Neutral → Overweight |
2023-12-19 | Eingeleitet | Wells Fargo | Equal Weight |
2023-12-13 | Eingeleitet | Wolfe Research | Outperform |
2022-10-21 | Eingeleitet | UBS | Buy |
2022-08-22 | Hochstufung | Citigroup | Neutral → Buy |
2021-10-15 | Fortgesetzt | Cowen | Market Perform |
2021-06-15 | Hochstufung | Cleveland Research | Neutral → Buy |
2021-02-05 | Herabstufung | Wells Fargo | Overweight → Equal Weight |
2020-12-02 | Eingeleitet | Goldman | Sell |
2020-11-16 | Hochstufung | Wolfe Research | Underperform → Peer Perform |
2020-05-01 | Herabstufung | Cleveland Research | Buy → Neutral |
2020-04-02 | Herabstufung | Wolfe Research | Peer Perform → Underperform |
2020-04-01 | Herabstufung | Needham | Strong Buy → Hold |
2020-03-26 | Hochstufung | Barclays | Equal Weight → Overweight |
2020-01-08 | Eingeleitet | Wells Fargo | Overweight |
2020-01-07 | Eingeleitet | Citigroup | Buy |
2019-11-15 | Eingeleitet | Stifel | Hold |
2019-09-26 | Hochstufung | BofA/Merrill | Neutral → Buy |
2019-07-15 | Hochstufung | Goldman | Sell → Neutral |
2019-06-24 | Bestätigt | Needham | Strong Buy |
2019-06-21 | Bestätigt | BofA/Merrill | Neutral |
2019-05-30 | Eingeleitet | Wolfe Research | Peer Perform |
2019-05-06 | Bestätigt | Needham | Strong Buy |
2019-05-03 | Hochstufung | SVB Leerink | Mkt Perform → Outperform |
2019-05-03 | Hochstufung | UBS | Sell → Neutral |
2019-04-12 | Hochstufung | Deutsche Bank | Hold → Buy |
2019-02-12 | Bestätigt | BTIG Research | Buy |
2019-01-03 | Eingeleitet | Needham | Strong Buy |
Alle ansehen
Bruker Corp Aktie (BRKR) Neueste Nachrichten
Bruker Corp (BRKR) Shares Up 3.22% on Jun 18 - GuruFocus
Q1 Earnings Outperformers: Bruker (NASDAQ:BRKR) And The Rest Of The Research Tools & Consumables Stocks - Yahoo Finance
Ex-Dividend Reminder: DTE Energy, HCA Healthcare and Bruker - Nasdaq
Dairy Analyzer | Bruker Optics Inc. | Products - Photonics Spectra
Bruker Corp (BRKR) Trading 4.64% Higher on Jun 10 - GuruFocus
Bruker Stock Set to Gain From Acquisition of Austria's biocrates - Yahoo Finance
Bruker Leads 3 Growth Stocks With Strong Insider Ownership - Yahoo Finance
Bruker acquires Austria based biocrates - MSN
Bruker introduces new timsUltra AIP System at ASMS 2025 - SelectScience
Bruker at Jefferies Conference: Strategic Growth Amid Challenges - Investing.com
biocrates life sciences ag becomes part of Bruker Group - SelectScience
Bruker launches revolutionary timsOmni mass spectrometer at ASMS 2025 - SelectScience
New proteoElute nanoLC System and PepSep Advanced nLC Columns showcased at ASMS 2025 - SelectScience
Bruker Applied MS Unveils Strategic Innovations at ASMS 2025, Showcasing Advances in DART Technology for TDM and DoA Analysis and Launching timsMetabo™ for PFAS and Environmental Contaminant Detection - Quantisnow
Bruker Corporation (BRKR) Acquires Biocrates to Expand Multiomics Solutions - Insider Monkey
Bruker invests in diagnostics, unveils new analysis platform By Investing.com - Investing.com Nigeria
Bruker's New Mass Spectrometry Platform Achieves 40% Higher Detection Rate for Environmental Contaminants - Stock Titan
Bruker (BRKR) Acquires Biocrates to Boost Metabolomics Solutions - GuruFocus
Should You Invest in Bruker Corp (BRKR)? - Insider Monkey
Bruker expands multiomics with biocrates acquisition - Investing.com
Bruker expands multiomics with biocrates acquisition By Investing.com - Investing.com Canada
Bruker (BRKR) Expands with Biocrates Life Sciences Acquisition | BRKR Stock News - GuruFocus
Bruker Announces Acquisition of biocrates, a Leader in Mass Spectrometry-based Quantitative Metabolomics - Quantisnow
Bruker unveils new mass spectrometer with enhanced sensitivity By Investing.com - Investing.com South Africa
Bruker (BRKR) Unveils Advanced Mass Spectrometer for 4D-Proteomics | BRKR Stock News - GuruFocus
Bruker unveils new mass spectrometer with enhanced sensitivity - Investing.com
Bruker (BRKR) Unveils Advanced Proteomics System at Industry Conference | BRKR Stock News - GuruFocus
Revolutionary Mass Spectrometer Breakthrough: Bruker's New System Detects Single Cell Proteins at Record Speed - Stock Titan
New Bruker LC System Delivers 50% Better Peptide Sensitivity in Proteomics | BRKR Stock News - Stock Titan
Zacks Research Has Optimistic Outlook of Bruker Q4 Earnings - Defense World
Bruker Leadership to Share Strategic Insights at Major Jefferies Healthcare Conference Next Week - Stock Titan
Bruker (BRKR) Introduces Advanced Mass Spectrometry System | BRK - GuruFocus
Bruker launches timsOmni system for advanced proteomics - Investing.com
Bruker Launches Revolutionary timsOmniTM Mass Spectrometer – Company Announcement - Financial Times
Bruker (BRKR) Unveils Advanced 4D-Metabolomics System | BRKR Stock News - GuruFocus
Zacks Research Has Pessimistic Outlook of Bruker Q2 Earnings - Defense World
Bruker unveils new timsMetabo system for metabolomics By Investing.com - Investing.com India
Bruker unveils new timsMetabo system for metabolomics - Investing.com
Breakthrough Mass Spectrometer Transforms Metabolomics Research with 4D Technology and AI Integration - Stock Titan
Bruker Launches Novel timsMetabo™ Mass Spectrometer for Breakthrough 4D-Metabolomics and 4D-Lipidomics Sensitivity, Specificity and Annotation Confidenceat Speed, Depth, and Scale - Yahoo Finance
Bruker Stock to Gain From the Launch of MOVE-T Liquid Dairy Analyzer - Yahoo Finance
Bruker launches MOVE-T for dairy quality control By Investing.com - Investing.com South Africa
Bruker Corp: Pan-Omics Dominance At A Margin Inflection Point (BRKR) - Seeking Alpha
Bruker launches MOVE-T for dairy quality control - Investing.com
Revolutionary MOVE-T System Transforms Dairy Quality Control: Bruker's New FT-NIR Analyzer Sets Industry Standard - Stock Titan
Bruker Corp (BRKR) Shares Up 4.51% on May 27 - GuruFocus
Deutsche Bank AG Has $865,000 Position in Bruker Co. (NASDAQ:BRKR) - Defense World
Bruker (BRKR) Downgraded by Citigroup with Price Target Lowered to $40 | BRKR Stock News - GuruFocus
Expert Outlook: Bruker Through The Eyes Of 8 Analysts - Benzinga
This Guidewire Software Analyst Is No Longer Bullish; Here Are Top 5 Downgrades For Thursday - Benzinga
Citi cuts Bruker stock rating, lowers price target to $40 - Investing.com
Finanzdaten der Bruker Corp-Aktie (BRKR)
Umsatz
Nettogewinn
Free Cashflow
ENV
Bruker Corp-Aktie (BRKR) Insiderhandel
Insiderhandel | Beziehung | Datum | Transaktion | Kosten | #Aktien | Wert ($) | #Aktien Gesamt |
---|---|---|---|---|---|---|---|
ORNELL JOHN A | Director |
May 13 '25 |
Option Exercise |
18.15 |
5,000 |
90,750 |
31,445 |
LINTON WILLIAM A | Director |
Apr 22 '25 |
Option Exercise |
24.00 |
10,000 |
240,000 |
58,723 |
Bures Thomas | Chief Accounting Officer |
Mar 10 '25 |
Buy |
47.40 |
500 |
23,698 |
3,472 |
LAUKIEN FRANK H | PRESIDENT & CEO |
Feb 18 '25 |
Buy |
50.92 |
20,000 |
1,018,330 |
38,459,563 |
PACKER RICHARD A | Director |
Dec 02 '24 |
Option Exercise |
19.12 |
10,000 |
191,200 |
84,254 |
PACKER RICHARD A | Director |
Dec 02 '24 |
Sale |
57.82 |
3,350 |
193,683 |
80,904 |
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):